[1] BURRI E, MAILLARD M, SCHOEPFER A, et al.Treatment algorithm for mild and moderate-to-severe ulcerative colitis: an update[J]. Digestion, 2020, 101(Suppl 1): 1-14. [2] SEHGAL P, COLOMBEL JF, ABOUBAKR A, et al.Systematic review: safety of mesalazine in ulcerative colitis[J]. Alimentary Pharmacology & Therapeutics, 2018, 47(12): 1597-1609. [3] VAN DER POST S, JABBAR KS, BIRCHENOUGH G, et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis[J]. Gut, 2019, 68(12): 2142-2151. [4] SCHIRMER M, DENSON L, VLAMAKIS H, et al.Compositional and temporal changes in the gut microbiome of pediatric ulcerative colitis patients are linked to disease course[J]. Cell Host Microbe, 2018, 24: 600-610. [5] HAIFER C,PARAMSOTHY S,KAAKOUSH NO, et al.Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial[J]. Lancet Gastroenterol Hepatol, 2022(72): 141-151. [6] CAPALDO CT, POWELL DN, KALMAN D.Layered defense: How mucus and tight junctions seal the intestinal barrier[J]. J Mol Med(Berl), 2017, 95(9): 927-934. [7] HOU J, HU M, ZHANG L, et al.Dietary taxifolin protects against dextran sulfate sodium-induced colitis via NF-κB signaling, enhancing intestinal barrier and modulating Gut Microbiota[J]. Front Immunol, 2021, 11: 631809. [8] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2020: 314-315. [9] ZHANG SS, ZHAO LQ.Review on the research progress of Chinese medicine in the treatment of ulcerative colitis[J]. Beijing Chinese Medicine(北京中医药), 2022, 41(9): 944-950. [10] ZHU L, CHENG C, LIU XJ, et al.Research status and thinking of ulcerative colitis with large intestine damp-heat syndrome[J]. Journal of Nanjing University of Traditional Chinese Medicine(南京中医药大学学报), 2023, 39(2): 188-193. [11] WENG YJ, ZHENG XB.Model of ulcerative colitis rats with damp-heat syndrome[J]. Lishizhen Medicine and Materia Medica Research(时珍国医国药), 2011, 22(10): 2522-2525. [12] SHANG W, WU H, CHEN Y, et al.Effects of linarin on intestinal mucosal barrier in mice with ulcerative colitis[J]. Immunological Journal, 2019, 38(5): 424-431. [13] DELGADO-RAMIREZ Y, COLLY V, GONZALEZ GV, et al.Signal transducer and activator of transcription 6 as a target in colon cancer therapy[J]. Oncol Lett, 2020, 20(1): 455-464. [14] BAYIK D, LATHIA JD.Cancer stem cell-immune cell crosstalk in tumour progression[J]. Nat Rev Cancer, 2021, 21(8): 526-536. [15] LIN SY, WANG YY, CHANG CY, et al.TNF-α receptor inhibitor alleviates metabolic and inflammatory changes in a rat model of ischemic stroke[J]. Antioxidants(Basel), 2021, 10(6): 851. [16] CHEN HD, YI B, LIU Q, et al.Diversity scaling of human digestive tract(DT) microbiomes: the intra-DT and inter-individual patterns[J]. Front Genet, 2021, 12: 724661. [17] YANG AL.A clinical primer of the role of gut microbiome in health and disease[J]. Tropical Gastroenterology, 2015, 36(1): 1-13. [18] DONG L, XIE J, WANG Y, et al.Mannose ameliorates experimental colitis by protecting intestinal barrier integrity[J]. Nat Commun, 2022, 13(1): 4804. |